# Hydroxychloroquine in Cystic Fibrosis

> **NCT00311883** · PHASE1 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 20 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** hydroxychloroquine

## Key facts

- **NCT ID:** NCT00311883
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2008-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311883, "Hydroxychloroquine in Cystic Fibrosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00311883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*